Streetbeat News

Products Services

JNJ

Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson (JNJ), has announced new Phase 3 results for Tremfya in Ulcerative Colitis, showing a 77% overall clinical response rate and early symptom improvement.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 7:17 pm

INTC

NVDA

NVIDIA's shares are trading higher following a report that the company will produce Arm-based PC chips, potentially challenging Intel.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 7:16 pm

INTC

Intel shares are trading lower following a report suggesting NVIDIA will make Arm-based PC chips, which could rival Intel.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 7:15 pm

ADSK

Autodesk has signed a definitive agreement to acquire FlexSim, a provider of simulation technology for factories and logistics centers. The acquisition will not have a material impact on Autodesk's Q4 and FY24 guidance. FlexSim's technology will complement Autodesk's existing factory design solutions and will be integrated into Autodesk's Design and Make Platform.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 7:12 pm

INTC

NVDA

Nvidia and Advanced Micro Devices are reportedly designing central processing units (CPUs) that would run Microsoft's Windows operating system and use technology from Arm Holdings. The chips could be sold as early as 2025, joining Qualcomm, which has been making Arm-based chips for laptops since 2016. This move is part of Microsoft's effort to help chip companies build Arm-based processors for Windows PCs, challenging Intel's dominance in the PC industry. Nvidia's shares rose 4.4% and Intel's shares dropped 2.9% following the news.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 7:09 pm

CBAY

CymaBay Therapeutics announced that the FDA has revised the Breakthrough Therapy Designation for seladelpar to include the treatment of primary biliary cholangitis, including pruritus in adults without cirrhosis or with compensated cirrhosis. This news has led to a rise in the company's stock.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 6:56 pm

AAPL

AMZN

BTCUSD

Seamus Rocca, CEO of Xapo Bank, shared insights on Bitcoin's potential to become a global reserve currency. He emphasized the need for broader institutional acceptance, clearer regulation, and dispelling misconceptions about Bitcoin's environmental impact. Xapo Bank, which serves as a custodian for Bitcoin, offers a deposit-guaranteed bank account that integrates with Bitcoin transactions. Rocca also hinted at upcoming features, including options for users to invest in S&P 500 tracker funds and buy stocks from companies like Apple and Amazon.

Portfolio Pulse from Murtuza Merchant

October 23, 2023 | 6:49 pm

AKU

APLM

INVO

LICY

LMDX

RVMD

U.S. stocks traded mixed with the Nasdaq Composite gaining over 100 points. Energy shares dipped by 1.9% while communication services shares rose by 1.3%. LumiraDx Limited, INVO Bioscience, and Akumin Inc. saw significant gains after strategic collaborations and acquisitions. Li-Cycle Holdings Corp., Revolution Medicines, and Apollomics, Inc. saw significant drops due to halted projects and clinical trial data. Oil traded down 2.6% to $85.79.

Portfolio Pulse from Lisa Levin

October 23, 2023 | 6:39 pm

EXEL

Exelixis announced detailed results from its Phase 3 CABINET pivotal trial evaluating cabozantinib in advanced neuroendocrine tumors, causing its shares to trade lower.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 6:05 pm

DIS

HAS

Hasbro, Inc. (NASDAQ:HAS) has expanded its relationship with Marvel, a subsidiary of Walt Disney Company (NYSE:DIS), to develop collectible products and tentpole sets for the trading card game, Magic: The Gathering. The first set based on Marvel's characters will appear globally in 2025. HAS shares are trading lower by 2.32% at $54.76.

Portfolio Pulse from Shivani Kumaresan

October 23, 2023 | 5:38 pm